Migraine and breast cancer risk: a prospective cohort study and meta-analysis.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 25505231)

Published in J Natl Cancer Inst on December 12, 2014

Authors

Anke C Winter1, Megan S Rice1, Renée T Fortner1, A Heather Eliassen1, Tobias Kurth1, Rulla M Tamimi1

Author Affiliations

1: Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO (ACW); Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (MSR, RTF, AHE, RMT); Department of Epidemiology, Harvard School of Public Health, Boston, MA (MSR, RTF, AHE, RMT); Division of Preventive Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (TK); Team Neuroepidemiology, INSERM ​Research Center for Epidemiology and Biostatistics (U897), Bordeaux, France (TK); University of Bordeaux, Bordeaux, France (TK).

Articles cited by this

Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA (2000) 55.37

Migraine and risk of cardiovascular disease in women. JAMA (2006) 6.16

Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem (1982) 5.98

Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (1998) 4.74

Determination of blood pressure percentiles in normal-weight children: some methodological issues. Am J Epidemiol (2008) 3.41

Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women. Cancer Res (2006) 2.27

Endogenous steroid hormone concentrations and risk of breast cancer: does the association vary by a woman's predicted breast cancer risk? J Clin Oncol (2006) 2.14

Reproducibility of plasma steroid hormones, prolactin, and insulin-like growth factor levels among premenopausal women over a 2- to 3-year period. Cancer Epidemiol Biomarkers Prev (2006) 2.14

The epidemiology of migraine. Am J Med (2005) 2.02

Agreement of self-reported migraine with ICHD-II criteria in the Women's Health Study. Cephalalgia (2009) 1.77

The influence of estrogen on migraine: a systematic review. JAMA (2006) 1.51

Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol (2013) 1.43

Migraine and reporoductive hormones throughout the menstrual cycle. Lancet (1975) 1.19

Migraine history and breast cancer risk among postmenopausal women. J Clin Oncol (2010) 1.11

Migraine in postmenopausal women and the risk of invasive breast cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.09

Premenopausal endogenous steroid hormones and breast cancer risk: results from the Nurses' Health Study II. Breast Cancer Res (2013) 1.08

Relationship between migraine history and breast cancer risk among premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prev (2009) 0.99

Migraine-associated risks and comorbidity. J Neurol (2008) 0.92

Migraine and subsequent risk of breast cancer: a prospective cohort study. Cancer Causes Control (2012) 0.91

Ovarian steroid levels in migraine with and without aura. Cephalalgia (1990) 0.83

Salivary cortisol, dehydroepiandrosterone-sulphate (DHEA-S) and testosterone in women with chronic migraine. J Headache Pain (2006) 0.82

Analgesic use in relation to sex hormone and prolactin concentrations in premenopausal women. Cancer Causes Control (2013) 0.82

Changes in the dopaminergic control of prolactin secretion and in ovarian steroids in migraine. Cephalalgia (1986) 0.82

Resolution of menstrually related migraine following aggressive treatment for breast cancer. Headache (2009) 0.79

Plasma met-enkephalin and catecholamine changes during the menstrual cycle and pain episode in menstrual migraine. Funct Neurol (1997) 0.78